About Biodeal Pharmaceuticals
Biodeal Pharmaceuticals is a company based in Delhi (India) founded in 2007 by Anurag Kumar.. Biodeal Pharmaceuticals has raised $13.2 million across 1 funding round from investors including Piramal Group. The company has 343 employees as of April 10, 2025. Biodeal Pharmaceuticals offers products and services including Domestic Pharmaceuticals, Nutraceuticals, Export Pharmaceuticals, and Derma and Cosmetics. Biodeal Pharmaceuticals operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Delhi, India
- Employees 343 as on 10 Apr, 2025
- Founders Anurag Kumar
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biodeal Pharmaceuticals Limited
- Date of Incorporation 30 Dec, 2005
- Jurisdiction Nalagarh, Distt. Solan (Hp)., Himachal Pradesh, India
-
Annual Revenue
$16.78 M (USD)41.92as on Mar 31, 2024
-
Net Profit
$1.29 M (USD)90.53as on Mar 31, 2024
-
EBITDA
$5.87 M (USD)177.98as on Mar 31, 2024
-
Total Equity Funding
$13.2 M (USD)
in 1 rounds
-
Latest Funding Round
$13.2 M (USD), Series B
Apr 08, 2024
- Investors
-
Employee Count
343
as on Apr 10, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biodeal Pharmaceuticals
Biodeal Pharmaceuticals offers a comprehensive portfolio of products and services, including Domestic Pharmaceuticals, Nutraceuticals, Export Pharmaceuticals, and Derma and Cosmetics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Manufactures drugs for Indian market with quality standards.
Produces nutritional products for health and wellness.
Develops formulations for international markets.
Creates skin care products for consumer use.
Unlock access to complete
Unlock access to complete
Funding Insights of Biodeal Pharmaceuticals
Biodeal Pharmaceuticals has successfully raised a total of $13.2M through 1 strategic funding round. The most recent funding activity was a Series B round of $13.2 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $13.2M
-
First Round
First Round
(08 Apr 2024)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2024 | Amount | Series B - Biodeal Pharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biodeal Pharmaceuticals
Biodeal Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Piramal Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biodeal Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biodeal Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biodeal Pharmaceuticals Comparisons
Competitors of Biodeal Pharmaceuticals
Biodeal Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| domain | founded_year | HQ Location |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| domain | founded_year | HQ Location |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| domain | founded_year | HQ Location |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| domain | founded_year | HQ Location |
CDMO with a focus on early phase drug product development
|
|
| domain | founded_year | HQ Location |
Cephalosporin APIs and generic formulations are manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Biodeal Pharmaceuticals
When was Biodeal Pharmaceuticals founded?
Biodeal Pharmaceuticals was founded in 2007 and raised its 1st funding round 17 years after it was founded.
Where is Biodeal Pharmaceuticals located?
Biodeal Pharmaceuticals is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Is Biodeal Pharmaceuticals a funded company?
Biodeal Pharmaceuticals is a funded company, having raised a total of $13.2M across 1 funding round to date. The company's 1st funding round was a Series B of $13.2M, raised on Apr 08, 2024.
How many employees does Biodeal Pharmaceuticals have?
As of Apr 10, 2025, the latest employee count at Biodeal Pharmaceuticals is 343.
What is the annual revenue of Biodeal Pharmaceuticals?
Annual revenue of Biodeal Pharmaceuticals is $16.78M as on Mar 31, 2024.
What does Biodeal Pharmaceuticals do?
Biodeal Pharmaceuticals was established in 2007 in Delhi, India, as a manufacturer of pharmaceutical formulations. Operations are centered on producing various drug formulations for the healthcare sector. The company is led by founder Anurag Kumar, serving as Managing Director. Activities are conducted from its base in Delhi, with a focus on standard pharmaceutical production processes. The domain biodealpharma.com is utilized for online presence.
Who are the top competitors of Biodeal Pharmaceuticals?
Biodeal Pharmaceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
What products or services does Biodeal Pharmaceuticals offer?
Biodeal Pharmaceuticals offers Domestic Pharmaceuticals, Nutraceuticals, Export Pharmaceuticals, and Derma and Cosmetics.
Who are Biodeal Pharmaceuticals's investors?
Biodeal Pharmaceuticals has 1 investor. Key investors include Piramal Group.